CAMTA1-AS2

Across TCGA pan-cancer cohorts, CAMTA1-AS2 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated CAMTA1-AS2 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher CAMTA1-AS2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CAMTA1-AS2 expression acts as an unfavorable survival marker, although some lineages such as UCEC and PAAD show a favorable association.

BLCA, ACC, and LIHC are the cancer types where CAMTA1-AS2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	III,IV	0.207	0.556	<.001	81	view →
ACC	OS	Tertile	All	0.199	0.747	.001	51	view →
LIHC	OS	Tertile	All	0.474	0.782	.008	39	view →
UCEC	DFS	Tertile	IV	0.973	0.606	.044	36	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	30	view →
LUAD	DFS	Tertile	IV	0.333	0.671	.048	27	view →
LGG	DFS	Tertile	All	0.328	0.440	<.001	23	view →
UVM	DFS	Tertile	II,III,IV	0.318	0.651	.026	18	view →
SKCM	DFS	Tertile	IV	0.016	0.541	.008	12	view →
PAAD	OS	Tertile	All	0.685	0.297	.042	9	view →
COAD	DFS	Tertile	IV	0.035	0.501	<.001	9	view →
KIRC	OS	Tertile	All	0.834	0.627	.026	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

CAMTA1-AS2–BLCA (DFS)

Open the BLCA breakdown →